Open Heart

Direct access CT coronary angiography in patients referred with suspected cardiac chest pain: a novel patient pathway

Background Rapid access chest pain (RACP) clinics are designed to expedite cardiac assessment, but current pathways cause ...

Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis

Viz.ai, the leader in AI-powered disease detection and care coordination, today announced a partnership with Alnylam Pharmaceuticals, the leading RNAi therapeutics company, to accelerate early ...
AHA/ASA Journals

Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome

BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...

HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification

HeartFocus, the AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced a partnership with Inteleos® through ...

Inteleos, Inc.: HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification

Rigorous training and certification gives clinicians a validated pathway to AI-enabled cardiac POCUS proficiencyROCKVILLE, Md. and BORDEAUX, France, April 07, 2026 (GLOBE NEWSWIRE) -- HeartFocus, the ...